Results 41 to 50 of about 55 (55)

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

Clinical Therapeutics, 2003
Lee Schwartzberg, Dianne Tomita, Greg Rossi   +2 more
exaly  

Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure

Advances in Therapy, 2007
Mehmet Kanbay, Tuncay Delibasi, Faruk Turgut   +2 more
exaly  

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

Kidney International, 2004
Michael Jones
exaly  

Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

American Journal of Health-System Pharmacy, 2005
Jon Herrington, Ralph V Boccia
exaly  

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C

Journal of Hepatology, 2004
Ming-Yang Lai, Giuseppe Pastore
exaly  

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)

Journal of Hepatology, 2002
Rajender Reddy, Coleman Smith, Samuel S Lee   +2 more
exaly  

Darbepoetin Alfa Therapeutic Interchange Protocol for Anemia in Dialysis

Annals of Pharmacotherapy, 2005
, Denise R Kockler
exaly  

Nanofibrillated cellulose from Alfa, Eucalyptus and Pine fibres: Preparation, characteristics and reinforcing potential

Carbohydrate Polymers, 2011
Sami Boufi, Manuel Rei Vilar
exaly  

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)

Journal of Hepatology, 2006
exaly  

Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia

Clinical Therapeutics, 2008
Joel Kallich, Ariel Berger, Gerry Oster   +2 more
exaly